<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Oxid Med Cell Longev</journal-id><journal-id journal-id-type="iso-abbrev">Oxid Med Cell Longev</journal-id><journal-id journal-id-type="publisher-id">OMCL</journal-id><journal-title-group><journal-title>Oxidative Medicine and Cellular Longevity</journal-title></journal-title-group><issn pub-type="ppub">1942-0900</issn><issn pub-type="epub">1942-0994</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6079351</article-id><article-id pub-id-type="doi">10.1155/2018/1261356</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Protective Effects of Fullerene C<sub>60</sub> Nanoparticles and Virgin Olive Oil against Genotoxicity Induced by Cyclophosphamide in Rats</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Aly</surname><given-names>Fayza M.</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Othman</surname><given-names>Amnah</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9484-0267</contrib-id><name><surname>Haridy</surname><given-names>Mohie A. M.</given-names></name><email>mohieharidy@svu.edu.eg</email><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="I1">
<sup>1</sup>Department of Zoology, Faculty of Science, South Valley University, Qena 83523, Egypt</aff><aff id="I2">
<sup>2</sup>Leibniz-Institut f&#x000fc;r Analytische Wissenschaften-ISAS-e.V., Bunsen-Kirchhoff-Stra&#x000df;e 11, 44139 Dortmund, Germany</aff><aff id="I3">
<sup>3</sup>Department of Pathology &#x00026; Clinical Pathology, Faculty of Veterinary Medicine, South Valley University, Qena 83523, Egypt</aff><author-notes><fn fn-type="other"><p>Academic Editor: Simona G. Bung&#x001ce;u</p></fn></author-notes><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>15</day><month>7</month><year>2018</year></pub-date><volume>2018</volume><elocation-id>1261356</elocation-id><history><date date-type="received"><day>10</day><month>3</month><year>2018</year></date><date date-type="rev-recd"><day>4</day><month>4</month><year>2018</year></date><date date-type="accepted"><day>11</day><month>4</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 Fayza M. Aly et al.</copyright-statement><copyright-year>2018</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>The potential effects of the fullerene C<sub>60</sub> nanoparticle (C<sub>60</sub>) as well as virgin olive oil (VOO) against the cyclophosphamide- (CP-) induced cytotoxic and mutagenic effects were evaluated by two main methods: molecular intersimple sequence repeat (ISSR) assay and cytogenetic biomarkers. Thirty adult male rats were divided to five groups (control, CP, C<sub>60</sub>, CP&#x02009;+&#x02009;C<sub>60</sub>, and CP&#x02009;+&#x02009;VOO). CP was i.p. injected with a single dose of 200&#x02009;mg/kg; C<sub>60</sub> and VOO were given orally (4&#x02009;mg/kg dissolved in VOO and 1&#x02009;ml, resp.) in alternative days for 20 days. The ISSR analysis revealed an increased in the DNA fragmentation level for liver and heart tissues represented by 21.2% and 32.6%, respectively, in the CP group. The DNA polymorphism levels were modulated and improved in CP&#x02009;+&#x02009;C<sub>60</sub> (8.9% and 12%) and CP&#x02009;+&#x02009;VOO (9.8% and 12.7%) for hepatic and cardiac tissues, respectively. The bone marrow cytogenetic analysis revealed that C<sub>60</sub> and VOO had significantly decreased the frequency of CP-induced chromosomal aberrations (chromosomal ring, deletion, dicentric chromosome, fragmentation, and polyploidy). Fullerene C<sub>60</sub> and VOO have ability to reduce DNA damage and decrease chromosomal aberrations. In conclusion, fullerene C<sub>60</sub> and VOO have protective effects against the CP-induced mutagenicity and genotoxicity. Fullerene C<sub>60</sub> and VOO open an interesting field concerning their potential antigenotoxic agents against deleterious side effects of chemotherapeutics.</p></abstract></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Commonly used anticancer agents, for example, cyclophosphamide, are implicated as mutagenic agents against mammalian cells <italic>in vivo</italic> and <italic>in vitro</italic> [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>]. Cyclophosphamide causes cytotoxicity to normal cells in spite of its effective anticancer alkylating agent [<xref rid="B3" ref-type="bibr">3</xref>]. The active metabolites of cyclophosphamide, for example, phosphoramide mustard and acrolein, are responsible for accumulation of reactive oxygen species resulting in fragmentation of the DNA strand and an increasing in mutagenic DNA effects [<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>]. The activated CP metabolites are responsible for inducing damage to DNA, RNA, proteins, and cytoplasmic membranes [<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>]. Therefore, it is necessary to investigate an effective antioxidant that prevents the oxidative DNA damage and reduces the side effects of CP and other chemotherapeutic agents.</p><p>Recently, carbon nanotubes, especially fullerene, have received considerable attention in the field of biomedical research and applications due to their distinct electrical properties. The interactions between carbon nanotubes, proteins, nucleic acids, and cell membranes as well as their mutagenicity and antimutagenicity assays have been investigated in order to discover potential antimutagen and anticarcinogen potentials [<xref rid="B8" ref-type="bibr">8</xref>]. Evaluation of chromosomal aberration is an effective assay to detect the occurrence of the genotoxicity. Detection of chromosomal aberration is an indicator for an organism exposure to the genotoxic agent and the occurrence of DNA damage. Various types of mutagens can induce structural chromosomal aberrations via DNA strand breaks that may elevate the risk of developing tumors [<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>]. It is necessary to approve potential drugs that can be used in protection and amelioration of cytotoxicity and DNA damage. The genotoxic effect of fullerene C<sub>60</sub> (C<sub>60</sub>) is controversial. C<sub>60</sub> has genotoxic activity resulting in breaks of the DNA strand as well as oxidative damages of DNA in a concentration-dependent manner. The basic mechanisms of its toxic effect are lipid peroxidation, oxidative stress dissemination, and genotoxicity [<xref rid="B11" ref-type="bibr">11</xref>&#x02013;<xref rid="B13" ref-type="bibr">13</xref>]. It was found that &#x00421;<sub>60</sub> toxicity depends on their surface modifications, synthesis, concentration in the medium, and processing conditions. On the other hand, numerous studies found no mutagenic effect of C<sub>60</sub> fullerene <italic>in vivo</italic> and <italic>in vitro</italic> [<xref rid="B14" ref-type="bibr">14</xref>&#x02013;<xref rid="B17" ref-type="bibr">17</xref>]. C<sub>60</sub> fullerene nanoparticle does not possess any genotoxic effect towards human lymphocytes. C<sub>60</sub> was used in combination with doxorubicin (one of the most common anticancer therapeutic agents); C<sub>60</sub> reduced the genotoxic effect of doxorubicin in healthy human lymphocytes [<xref rid="B18" ref-type="bibr">18</xref>]. Furthermore, &#x00421;<sub>60</sub> possesses an ability to prevent oxidative stress dissemination due to the nanosize [<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>].</p><p>Olive oil-containing meals reduce the risk of many diseases and malignant tumors, as they have antioxidative, anti-inflammatory, and anticarcinogenic effects [<xref rid="B21" ref-type="bibr">21</xref>]. Oleuropein and hydroxytyrosol are important components of virgin olive oil (VOO); they have anticancer activity through reducing DNA oxidation, arresting the cell cycle, and inducing apoptosis in tumor cells [<xref rid="B22" ref-type="bibr">22</xref>]. High consumption of VOO in the Mediterranean diet has been suggested to be responsible for protection of DNA against perioxidation and hence reduction in cancer incidence. So, it was found that DNA and RNA oxidation in Northern European regions is higher compared with that in central and Southern regions. These findings support the assumption that VOO consumption may explain the decreased incidence of cancer in south European than those in North regions [<xref rid="B23" ref-type="bibr">23</xref>]. It is necessary to investigate the effect of C<sub>60</sub> nanoparticle and VOO separately and in combination against CP-induced genotoxicity. Therefore, the objective of this study is to assess the effect of C<sub>60</sub> as well as VOO on CP-induced genotoxicity in rats based on detection of DNA damage by intersimple sequence repeat (ISSR) analysis of liver and heart tissues and detection of chromosomal aberrations in bone marrow cells by mitotic analysis technique.</p></sec><sec id="sec2"><title>2. Materials and Methods</title><sec id="sec2.1"><title>2.1. Animals, Experimental Design, and Sampling</title><p>Thirty male albino rats (weighing 180&#x02013;200&#x02009;g, 2-month old) were housed in Animal House Facility (South Valley University, Qena, Egypt). Rats were housed under normal nutritional and laboratory conditions for one week for acclimatization. Animals were kept in the ventilated room under controlled laboratory conditions of normal light-dark cycle (12&#x02009;h light/dark) and temperature (25&#x02009;&#x000b1;&#x02009;2&#x000b0;C). Food and water were provided ad libitum. Rats were divided into 5 groups (<italic>n</italic> = 6 rats each group) as follows: (i) control group received placebo intraperitoneal (i.p.) injection; (ii) CP group was injected i.p. with a single dose of CP (200&#x02009;mg/kg dissolved in 2&#x02009;ml distilled water (DW)); (iii) C<sub>60</sub> group was given orally of C<sub>60</sub> (4&#x02009;mg/kg dissolved in 1&#x02009;ml VOO) in alternative days for 20 days according to [<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B25" ref-type="bibr">25</xref>]; (iv) CP&#x02009;+&#x02009;C<sub>60</sub> group was injected i.p. with a single dose of CP (200&#x02009;mg/kg dissolved in 2&#x02009;ml DW) and given orally 4&#x02009;mg/kg dissolved in 1&#x02009;ml VOO of C<sub>60</sub> in alternative days for 20 days; and (v) CP&#x02009;+&#x02009;VOO group was injected i.p. with a single dose of CP (200&#x02009;mg/kg dissolved in 2&#x02009;ml DW and treated orally with VOO (1&#x02009;ml in alternative days for 20 days). The experimental animal protocols were carried out by following the guidelines for animal care and were approved by the Ethical Animal Care and Use Committee from the Faculty of Veterinary Medicine, South Valley University, Egypt (application number: VetEg.0465R-2017-2018). After 45 days, the treatments were stopped and rats were left for 24 hours, then three animals from each group were sacrificed. Efforts were maximized to minimize pain suffering of animals. The animals were scarified by cervical dislocation under deep anesthesia using diethyl ether. The whole liver and heart were collected in Carnoy's solution for fixation and frozen at &#x02212;80&#x000b0;C until used for DNA extraction. Bone marrow aspiration for cytogenetic analysis was performed in all rats.</p></sec><sec id="sec2.2"><title>2.2. Chemicals and Fullerene C<sub>60</sub> Preparation</title><p>Cyclophosphamide (Endoxan) was delivered as vials (Baxter Oncology, Halle, Germany), and VOO was commercially purchased (Colavita Extra Virgin Olive Oil Company, New Jersey, USA). Mixture of fullerene C<sub>60</sub> (99.9% purity) (Shanghai Boyle Chemical Co. Ltd., China) and VOO was prepared according to Baati et al. [<xref rid="B24" ref-type="bibr">24</xref>] and Elshater et al. [<xref rid="B25" ref-type="bibr">25</xref>] as follows: one gram of C<sub>60</sub> was dissolved in VOO (200&#x02009;ml), stirred at ambient temperature in dark for 15 days, and centrifuged (5000&#x02009;rpm) for 1&#x02009;h. Using 0.25&#x02009;<italic>&#x003bc;</italic>m Millipore filters, the supernatant was filtered through and administered immediately.</p></sec><sec id="sec2.3"><title>2.3. DNA Extraction</title><p>Carnoy's fixed and frozen liver and heart tissues were used for DNA extraction using QIAamp DNA Mini Kit (Qiagen, Santa Clarita, CA). DNA fragmentation in liver and heart tissues was carried out according to the kit manufacturer's protocol. Briefly, liver or heart tissues (20&#x02009;mg) were grinded in hypotonic lysis buffer (400&#x02009;<italic>&#x003bc;</italic>l; 10&#x02009;mM Tris base, 1&#x02009;mM EDTA, and 0.2% Triton X-10), and the cells were centrifuged (10,000&#x02009;rpm) at 4&#x000b0;C for 5&#x02009;min. The supernatant (containing small DNA fragments) was mixed with equal volumes of 0.5&#x02009;M NaCl and absolute isopropyl alcohol for precipitation of DNA. Mixture was stored at &#x02212;20&#x000b0;C overnight, then centrifuged (11,000&#x02009;rpm) at 4&#x000b0;C for 15&#x02009;min. Ethanol (200&#x02009;<italic>&#x003bc;</italic>l of 70%) was used for washing the pellet; then, the pellet was loaded into the elution column and washed twice with buffer, and the DNA was isolated using elution buffer. The eluted DNA was stored at &#x02212;20&#x000b0;C until use [<xref rid="B26" ref-type="bibr">26</xref>].</p></sec><sec id="sec2.4"><title>2.4. Polymerase Chain Reaction of ISSR Analysis</title><p>Five primers (Eurofins, Germany) (<xref rid="tab1" ref-type="table">Table 1</xref>) were used in intersimple sequence repeat (ISSR) analysis, and PCR cycling was performed in a TakaRa Thermal Cycler (Takara Bio Inc., Shiga, Japan). For ISSR analysis, PCR amplification reactions [<xref rid="B27" ref-type="bibr">27</xref>] were used in a volume of 25&#x02009;<italic>&#x003bc;</italic>l (1X of Green GoTaq&#x000ae; Flexi Buffer, primer (25&#x02009;pucM), dNTPs (200&#x02009;<italic>&#x003bc;</italic>M, Promega), MgCl<sub>2</sub> (1.5&#x02009;mM), GoTaq Flexi DNA Polymerase (1&#x02009;U, Promega), template DNA (25&#x02009;ng), and up to 25&#x02009;<italic>&#x003bc;</italic>l DW). The reactions were carried out in the following conditions: initial denaturation process (1&#x02009;cycle) was performed at 94&#x000b0;C for 5&#x02009;min; annealing (40&#x02009;cycles) was carried out at 94&#x000b0;C for 45&#x02009;sec, 45&#x000b0;C for 50&#x02009;sec, and 72&#x000b0;C for 1.5&#x02009;min; and lastly, extension (1&#x02009;cycle) was done at 72&#x000b0;C for 7&#x02009;min.</p></sec><sec id="sec2.5"><title>2.5. Agarose Gel Electrophoresis</title><p>PCR products were analyzed using agarose gel electrophoresis (1.5%) and visualized with ethidium bromide (10&#x02009;<italic>&#x003bc;</italic>g/<italic>&#x003bc;</italic>l) staining. The gels were exposed to UV light and photographed using a Molecular Imager&#x000ae; Gel Doc&#x02122; System with Image Lab&#x02122; Software, Bio-Rad. The size of the DNA fragments was estimated based on a DNA ladder (100 to 2000&#x02009;bp, MBI, Fermentas). The presence or absence of each band was treated as binary character in a data matrix, that is, coded 1 and 0, respectively, The amplification products were scored as (1) for the presence and (0) for the absence of the bands and were compared to the bands in the control group to determine the genetic alterations across the other treated groups. The appearance of new bands and disappearance of existed bands in comparison with the control group are considered DNA polymorphism. Percentage of polymorphism is calculated according to this equation: number of polymorphic DNA band&#x02009;&#x000d7;&#x02009;100/total number of bands.</p></sec><sec id="sec2.6"><title>2.6. Preparation of Chromosome for Chromosomal Aberration Analysis</title><p>Microscopic slides for mitotic chromosomal spread were prepared as described by Yosida and Amano [<xref rid="B28" ref-type="bibr">28</xref>]. Rats were injected i.p. with colchicines (0.05%) and then euthanized 2&#x02009;h later. Femurs of rats were removed, and the bone marrow cells were aspirated from both femurs in warmed hypotonic solution (5-6&#x02009;ml of 0.56% KCl) for 30&#x02009;min. The aspirate was centrifuged, and the supernatant was decanted. The resultant cellular mass was fixed three times in a mixture of (3&#x02009;:&#x02009;1) methanol-glacial acetic acid. Slides were prepared by dropping the cell suspension onto ethanol-cold slides and flaming them slightly. The slides were stained with Giemsa (10%) in phosphate buffer (pH&#x02009;6.8). In each group, approximately 250 metaphase spreads were analyzed and the structural chromosomal aberrations per cell were counted. Different types of chromosomal aberrations such as chromosomal ring, chromatid deletion, dicentric chromosomes, chromosome fragments, and polyploidy chromosomes were accounted. The data was expressed as chromosomal aberration percentage (%) in each group using the following formula: chromosomal aberration %&#x02009;=&#x02009;total number of chromosomal aberrations&#x02009;&#x000d7;&#x02009;100/total number of counted metaphase spreads (250).</p></sec><sec id="sec2.7"><title>2.7. Statistical Analysis</title><p>Statistical analysis was carried out using the Student's <italic>t</italic>-test (two-tailed) with SPSS 24 software. Chromosomal aberrations are expressed as mean&#x02009;&#x000b1;&#x02009;SE. Differences were considered as significant when <italic>P</italic> &#x0003c; 0.05.</p></sec></sec><sec id="sec3"><title>3. Results</title><sec id="sec3.1"><title>3.1. Genotoxic Changes in Hepatic and Cardiac Tissues</title><p>ISSR analysis of the hepatic and cardiac tissues was performed to assess the genotoxicity of CP and the effect of C<sub>60</sub> and VOO on CP-induced genotoxicity in rats. Numbers of ISSR bands ranged between 8 and 15 and 9 and 17 in hepatic and cardiac tissues, respectively (Figures <xref ref-type="fig" rid="fig1">1</xref> and <xref ref-type="fig" rid="fig2">2</xref>, <xref rid="tab2" ref-type="table">Table 2</xref>). The amplified bands had molecular weight of genomic DNA ranged between 160 and 1400&#x02009;bp for both the hepatic and cardiac tissues, with 12 band average per primer (Figures <xref ref-type="fig" rid="fig1">1</xref> and <xref ref-type="fig" rid="fig2">2</xref>, <xref rid="tab2" ref-type="table">Table 2</xref>). In the control group, there were 57 ISSR bands in liver samples, compared to 52, 57, 56, and 61 bands in CP, C<sub>60</sub>, CP&#x02009;+&#x02009;C<sub>60</sub>, and CP&#x02009;+&#x02009;VOO groups, respectively. The CP group exhibited the highest number of lost bands. The number of lost bands caused by CP was decreased after treatment with C<sub>60</sub> or VOO (<xref rid="tab2" ref-type="table">Table 2</xref>). CP-induced loss in bands has been improved through treatment with C<sub>60</sub>, as well as VOO.</p><p>In cardiac tissues, ISSR bands were 53, 46, 53, 50, and 55 in control, CP, C<sub>60</sub>, CP&#x02009;+&#x02009;C<sub>60</sub>, and CP&#x02009;+&#x02009;VOO groups, respectively (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref rid="tab2" ref-type="table">Table 2</xref>). Similarly, rats treated with CP had the highest number of ISSR band loss, and treatment with C<sub>60</sub> or VOO decreased the band loss and recovered to control levels. Treatment with C<sub>60</sub> and VOO improved the CP-induced genotoxicity. Furthermore, cardiac muscles were more affected by genotoxic effects of CP than hepatic tissues, and the rate of improvement due to treatment with C<sub>60</sub> was lower than that observed in hepatic tissue.</p><p>The highest polymorphic bands were produced by the ISSR-3 and ISSR-1 primers (71.4% and 50% in hepatic and cardiac tissues, resp.) in the CP group (<xref rid="tab3" ref-type="table">Table 3</xref>), whereas the lowest polymorphic bands were produced by ISSR-5 and ISSR-2 (0% and 9.1%) in hepatic and cardiac tissues, respectively (<xref rid="tab3" ref-type="table">Table 3</xref>).</p></sec><sec id="sec3.2"><title>3.2. Attenuation of CP-Induced Polymorphism in Hepatic and Cardiac Tissues after Treatment with Fullerene C<sub>60</sub> and VOO</title><p>Genetic analysis revealed that CP induced 11 polymorphic bands out of 52 bands (21.2% polymorphism) detected in the hepatic tissues (<xref rid="tab3" ref-type="table">Table 3</xref>). In cardiac tissues, CP produced 15 polymorphic bands out of 46 bands (32.6% polymorphism) (<xref rid="tab3" ref-type="table">Table 3</xref>). In contrast, the percentages of polymorphism in fullerene C<sub>60</sub> (7%), CP&#x02009;+&#x02009;C<sub>60</sub> (8.9%), and CP&#x02009;+&#x02009;VOO (9.8%) were lower than those recorded in CP (21.2%) in liver tissues (<xref rid="tab3" ref-type="table">Table 3</xref>). Band polymorphism in cardiac tissues is recorded in <xref rid="tab3" ref-type="table">Table 3</xref>. The percentages of polymorphism were 32.6, 11.3, 12, and 12.7% in cardiac tissues of CP, C<sub>60</sub>, CP&#x02009;+&#x02009;C<sub>60</sub>, and CP&#x02009;+&#x02009;VOO groups, respectively. Livers and hearts from rats exposed to C<sub>60</sub> dissolved in VOO (C<sub>60</sub> group) showed 7% and 11.3% polymorphisms, respectively (<xref rid="tab3" ref-type="table">Table 3</xref>). These results indicate that polymorphisms induced by CP can be attenuated by C<sub>60</sub> or VOO (in CP&#x02009;+&#x02009;C<sub>60</sub> and CP&#x02009;+&#x02009;VOO groups).</p><p>Comparison of polymorphism percentages in cardiac muscles in all groups with those of hepatic tissues indicated that cardiac muscles (32.6% in CP) were more sensitive to CP genotoxicity than hepatic tissues (21.2% in CP) and the latter was better in response to the effect of C<sub>60</sub> and VOO in moderation, reduction, or attenuation of CP toxic effects. Moreover, treatment with C<sub>60</sub> was more effective than with VOO in improving the CP-induced genetic toxicity.</p></sec><sec id="sec3.3"><title>3.3. Cyclophosphamide-Induced Chromosomal Aberrations and Effect of C<sub>60</sub> and VOO</title><p>The chromosomal alterations in bone marrow cells due to CP, C<sub>60</sub>, and VOO were recorded. The CP group had the highest level (23.00&#x02009;&#x000b1;&#x02009;14.28) of aberrant chromosomes (<xref ref-type="fig" rid="fig3">Figure 3</xref>, <xref rid="tab4" ref-type="table">Table 4</xref>) in comparison to other treated groups. The major chromosomal aberrations were the formation of chromosomal rings (40.0%) (<xref rid="tab4" ref-type="table">Table 4</xref>, <xref ref-type="fig" rid="fig3">Figure 3</xref>). Dicentric chromosomes (Figures <xref ref-type="fig" rid="fig3">3(d)</xref> and <xref ref-type="fig" rid="fig3">3(g)</xref>), chromosomal fragments (<xref ref-type="fig" rid="fig3">Figure 3(e)</xref>), chromatid deletions (Figures <xref ref-type="fig" rid="fig3">3(c)</xref>, <xref ref-type="fig" rid="fig3">3(e)</xref>, and <xref ref-type="fig" rid="fig3">3(f)</xref>), and polyploidy were recorded after CP treatment, representing 4.00%, 3.5%, 6.0%, and 4.0%, respectively. Rats cotreated with CP and C<sub>60</sub> or VOO reduced significantly the percentage of chromosomal aberrations when compared to those with CP alone. The frequencies of total chromosomal aberrations were 0.40&#x02009;&#x000b1;&#x02009;0.24, 23.0&#x02009;&#x000b1;&#x02009;14.28, 8.20&#x02009;&#x000b1;&#x02009;3.29, 10.40&#x02009;&#x000b1;&#x02009;5.10, and 11.20&#x02009;&#x000b1;&#x02009;6.23 in control-, CP-, C<sub>60</sub>-, CP&#x02009;+&#x02009;C<sub>60</sub>-, and CP&#x02009;+&#x02009;VOO-treated animals, respectively. The percentages of total aberrant chromosomes were 1, 57.5, 20.5, 26.0, and 28% in control, CP, C<sub>60</sub>, CP&#x02009;+&#x02009;C<sub>60</sub>, and CP&#x02009;+&#x02009;VOO groups, respectively (<xref rid="tab4" ref-type="table">Table 4</xref>). Phenotype of chromosomal ring was reduced significantly after treatment with C<sub>60</sub> or VOO (<xref rid="tab4" ref-type="table">Table 4</xref>, <xref ref-type="fig" rid="fig3">Figure 3</xref>). Other chromosomal changes such as deletion, dicentric chromosome, fragmentation, and polyploidy were reduced in number and percentage in treatment groups (C<sub>60</sub>, CP&#x02009;+&#x02009;C<sub>60</sub>, and CP&#x02009;+&#x02009;VOO) compared with those in the CP group (<xref rid="tab4" ref-type="table">Table 4</xref>, <xref ref-type="fig" rid="fig3">Figure 3</xref>). The total numbers of aberrant chromosomes in 250 bone marrow cells were 2, 115, 41, 52, and 56 in control, CP, C<sub>60</sub>, CP&#x02009;+&#x02009;C<sub>60</sub>, and CP&#x02009;+&#x02009;VOO, respectively (<xref rid="tab4" ref-type="table">Table 4</xref>). C<sub>60</sub> and VOO significantly reduced chromosomal aberrations (50% reduction or more) in comparison with CP-treated rats.</p></sec></sec><sec id="sec4"><title>4. Discussion</title><p>CP is used as a cancer chemotherapy alkylating agent. Active compounds of CP are acrolein and phosphoramide which are responsible for reducing the growth of cancerous cells by acting at the DNA level [<xref rid="B29" ref-type="bibr">29</xref>]. On the other hand, CP can enhance secondary tumors in healthy human tissues such as urinary bladder tumors as well as metastasis occasionally [<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>]. CP, as a prooxidant, is used for treatment for a long time which leads to oxidative stress through generation of free radicals. After CP treatment, antioxidant enzyme activities decreased and lipid peroxidation increased [<xref rid="B32" ref-type="bibr">32</xref>]. Moreover, CP-induced genotoxicity is a dose-dependent manner. Although CP is used as an anticancer drug which is necessary to kill the carcinogenic cells, the increase use of CP in the treatment period leads to cytotoxicity of healthy cells in the body [<xref rid="B5" ref-type="bibr">5</xref>]. CP chemotherapy induces a variety of changes in DNA and proteins that lead to imbalance in cell division. In the present study, CP decreased the DNA level and increased the chromosomal aberrations in rat tissues. Most of chemotherapeutic agents and CP cause gene mutations, chromosomal aberrations, and rearrangements in somatic and germ cells of experimental animals [<xref rid="B33" ref-type="bibr">33</xref>]. Protection against CP chemotherapy-induced genotoxicity is a hot research point. Many mechanisms have been adopted to deal with CP genotoxicity, and several antimutagens were recorded acting in rodents and may be active in human too [<xref rid="B34" ref-type="bibr">34</xref>]. The objective of the current study was to assess the effect of fullerene C<sub>60</sub> nanoparticles as well as VOO to ameliorate CP-induced genotoxicity. Previous studies were demonstrating an improved effect of some extracts and chemicals such as garlic and <italic>Ocimum sanctum</italic> on the chromosomal aberrations [<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B36" ref-type="bibr">36</xref>]. This study investigated the antigenotoxic activity of fullerene C<sub>60</sub> as well as VOO in rat tissues by two main methods, molecular assays and cytogenetic biomarkers using DNA fragmentation assay in liver and heart tissues and chromosomal aberrations in bone marrow cells, respectively. CP produced severe mutations in DNA strands and chromosomes giving the ability to fairly judge on the DNA repair and cytogenetic activity of C<sub>60</sub> and VOO in rats <italic>in vivo</italic>. CP induced loss of ISSR bands that decreased by cotreatment with C<sub>60</sub> or VOO. CP-induced loss in bands has been improved through treatment with C<sub>60</sub>, as well as VOO. Moreover, treatment with C<sub>60</sub> was more effective than with VOO in improving the CP-induced genetic toxicity because the percentages of DNA polymorphism in hepatic and cardiac tissues were 8.9% and 9.8% and 12 and 12.7% in CP&#x02009;+&#x02009;C<sub>60</sub> and CP&#x02009;+&#x02009;VOO groups, respectively. Fullerene C<sub>60</sub> causes no damage in DNA strands and had no impact on the level of aberrant chromosomes <italic>in vivo</italic> and <italic>in vitro</italic> [<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B38" ref-type="bibr">38</xref>]. In the present study, C<sub>60</sub> and VOO induced an improved DNA level and decreased the chromosomal aberration in CP&#x02009;+&#x02009;C<sub>60</sub> or CP&#x02009;+&#x02009;VOO compared to that in the CP group. Fullerene nanoparticles (C<sub>60</sub>) possess an ability to protect against oxidative stress and may decrease mutagenic activity, due to the nanosize [<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B39" ref-type="bibr">39</xref>]. In contrast, few reports stated that C<sub>60</sub> possesses genotoxic activity in different animal tissues where it induces breaks and oxidative damages of in the DNA strand [<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B41" ref-type="bibr">41</xref>]. In the present study, C<sub>60</sub> improved the lost ISSR bands in both hepatic (57 and 56 in C<sub>60</sub> and CP&#x02009;&#x02212;&#x02009;C<sub>60</sub>, resp.) and cardiac (53 and 50 in C<sub>60</sub> and CP&#x02009;&#x02212;&#x02009;C<sub>60</sub>, resp.) tissues when compared to those of CP (52 and 46), respectively. Moreover, C<sub>60</sub> decreased the percentage of DNA polymorphism in hepatic (7% and 8.9% in C<sub>60</sub> and CP&#x02009;&#x02212;&#x02009;C<sub>60</sub>, resp.) and cardiac (11.3% and 12% in C<sub>60</sub> and CP&#x02009;&#x02212;&#x02009;C<sub>60</sub>, resp.) tissues when compared to that of CP (21.2% and 32.6%), respectively. Effect of C<sub>60</sub> on tissues <italic>in vivo</italic> and <italic>in vitro</italic> studies depends on the size of nanoparticles, the given dose, duration of exposure, and type of cells [<xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B42" ref-type="bibr">42</xref>]. In the present study, low dose of C<sub>60</sub> was 4&#x02009;mg/kg dissolved in VOO as those recorded by Baati et al. [<xref rid="B24" ref-type="bibr">24</xref>] and Elshater et al. [<xref rid="B25" ref-type="bibr">25</xref>] as low doses are protective against oxidative stress.</p><p>Effect of C<sub>60</sub> on CP-induced hepatotoxicity was more effective than its effect on CP-induced cardiotoxicity and triggered a better response against genotoxicity in the liver than in the heart. Comparison of polymorphism percentages in cardiac muscles in all groups with those of hepatic tissues indicated that cardiac muscles (32.6% in CP) were more sensitive to CP genotoxicity than hepatic tissues (21.2% in CP). Cardiac muscles were worse in response to the effect of C<sub>60</sub> and VOO than hepatic tissue in moderation, reduction, or attenuation of CP toxic effects.</p><p>The chromosomal aberration is an important parameter for investigating the protective effects of antigenotoxic agents on chemical and drug-induced toxicity. C<sub>60</sub> had no genotoxic effects, and it induced antigenotoxic effects at subcytotoxic concentrations on human lymphocytes, presented by the decreased in micronuclei and chromosomal aberration frequency [<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B38" ref-type="bibr">38</xref>]. Moreover, C<sub>60</sub> prevents the toxic effect of doxorubicin (chemotherapeutic agent) on normal cells and possesses no genotoxic effect on human lymphocytes [<xref rid="B18" ref-type="bibr">18</xref>]. C<sub>60</sub> has a potential antioxidative effect against CP-induced hepatotoxicity [<xref rid="B25" ref-type="bibr">25</xref>]. In the present work, in spite of C<sub>60</sub> induced few genotoxic features represented by a few number of chromosomal aberration, for example, chromosomal ring, chromosomal fragments, and chromatid deletions, C<sub>60</sub> had a protective effect against CP-induced genotoxicity. C<sub>60</sub> as well as VOO decreased the number and types of aberrant chromosomes in CP&#x02009;+&#x02009;C<sub>60</sub> and CP&#x02009;+&#x02009;VOO groups, respectively, when compared to the treatment by CP alone. Similar findings have been approved by C<sub>60</sub> and VOO against cadmium-induced genotoxicity [<xref rid="B43" ref-type="bibr">43</xref>]. Fullerene C<sub>60</sub> and VOO significantly ameliorate cadmium chloride-induced genotoxicity in hepatic and renal tissues. Moreover, they reversed the chromosomal alterations caused by cadmium chloride toxicity on bone marrow [<xref rid="B43" ref-type="bibr">43</xref>].</p><p>Moreover, VOO had an antigenotoxic impact on rat tissues. Our molecular studies on ISSR in hepatic and cardiac tissues as well as cytogenetic of bone marrow cells indicated that VOO alleviated CP-induced genotoxicity. Similarly, Fabiani et al. [<xref rid="B22" ref-type="bibr">22</xref>] reported that olive oil has a protective activity against cancer through arrest of the cell cycle and induction of apoptosis in tumor cells and also it has cytotoxic as well as cytoprotective compounds with potential pharmaceutical properties. VOO has a potential antioxidative effect, and it protects DNA from damage induced by a toxic material or a chemotherapeutic agent [<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B45" ref-type="bibr">45</xref>]. This study displays the antioxidant and antigenotoxic activities of fullerene C<sub>60</sub> nanoparticle and olive oil and its antimutagenic impacts in reducing the DNA damage, which can be occurred in healthy cells as side effect of the treatment with cyclophosphamide.</p></sec><sec id="sec5"><title>5. Conclusion</title><p>The present study investigated the antigenotoxic activity of C<sub>60</sub> as well as VOO in hepatic and cardiac tissues of a rat after induction of genotoxicity by CP. Two main methods were performed molecular ISSR assay and cytogenetic biomarkers using DNA fragmentation of liver and heart tissues and chromosomal aberrations in bone marrow cells, respectively. CP made severe mutations in DNA strands and chromosomal aberration; in contrast, DNA band numbers return to the control level as well as the chromosomal aberration frequency decreased significantly after C60 and VOO treatments. This study investigated the antigenotoxic activities of C<sub>60</sub> nanoparticle and VOO and its antimutagenic impacts in reducing the DNA damage in healthy cells (C<sub>60</sub> group) and after genotoxicity (CP&#x02009;+&#x02009;C<sub>60</sub> and CP&#x02009;+&#x02009;VOO groups). Virgin olive oil has potent antigenotoxic effect compared with C<sub>60</sub>. Cardiac muscles were more susceptible to CP-induced genotoxicity and less responsive to C<sub>60</sub> and VOO treatments than hepatic tissues. These findings highlight the principles for the future research possibilities to design and develop C<sub>60</sub>- and VOO-related drugs combined to CP and other chemotherapeutics, which might minimize the side effects caused by the commonly used chemotherapeutic agent.</p></sec></body><back><sec sec-type="data-availability"><title>Data Availability</title><p>The data used to support the findings of this study are available from the corresponding author upon request.</p></sec><sec><title>Conflicts of Interest</title><p>The authors declare that there are no conflicts of interest to disclose.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szikriszt</surname><given-names>B.</given-names></name><name><surname>P&#x000f3;ti</surname><given-names>&#x000c1;.</given-names></name><name><surname>Pipek</surname><given-names>O.</given-names></name><etal/></person-group><article-title>A comprehensive survey of the mutagenic impact of common cancer cytotoxics</article-title><source><italic toggle="yes">Genome Biology</italic></source><year>2016</year><volume>17</volume><issue>1</issue><fpage>p. 99</fpage><pub-id pub-id-type="doi">10.1186/s13059-016-0963-7</pub-id><pub-id pub-id-type="other">2-s2.0-84973401146</pub-id><?supplied-pmid 27161042?><pub-id pub-id-type="pmid">27161042</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glen</surname><given-names>C. D.</given-names></name><name><surname>Dubrova</surname><given-names>Y. E.</given-names></name></person-group><article-title>Exposure to anticancer drugs can result in transgenerational genomic instability in mice</article-title><source><italic toggle="yes">Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2012</year><volume>109</volume><issue>8</issue><fpage>2984</fpage><lpage>2988</lpage><pub-id pub-id-type="doi">10.1073/pnas.1119396109</pub-id><pub-id pub-id-type="other">2-s2.0-84857376665</pub-id><?supplied-pmid 22308437?><pub-id pub-id-type="pmid">22308437</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D. J.</given-names></name><name><surname>Kim</surname><given-names>E. J.</given-names></name><name><surname>Lee</surname><given-names>T. Y.</given-names></name><name><surname>Won</surname><given-names>J. N.</given-names></name><name><surname>Sung</surname><given-names>M. H.</given-names></name><name><surname>Poo</surname><given-names>H.</given-names></name></person-group><article-title>Combination of poly-gamma-glutamate and cyclophosphamide enhanced antitumor efficacy against tumor growth and metastasis in a murine melanoma model</article-title><source><italic toggle="yes">Journal of Microbiology and Biotechnology</italic></source><year>2013</year><volume>23</volume><issue>9</issue><fpage>1339</fpage><lpage>1346</lpage><pub-id pub-id-type="doi">10.4014/jmb.1306.06071</pub-id><pub-id pub-id-type="other">2-s2.0-84884677967</pub-id><?supplied-pmid 23867701?><pub-id pub-id-type="pmid">23867701</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rehman</surname><given-names>M. U.</given-names></name><name><surname>Tahir</surname><given-names>M.</given-names></name><name><surname>Ali</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Cyclophosphamide-induced nephrotoxicity, genotoxicity, and damage in kidney genomic DNA of Swiss albino mice: the protective effect of Ellagic acid</article-title><source><italic toggle="yes">Molecular and Cellular Biochemistry</italic></source><year>2012</year><volume>365</volume><issue>1-2</issue><fpage>119</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1007/s11010-012-1250-x</pub-id><pub-id pub-id-type="other">2-s2.0-84860239947</pub-id><?supplied-pmid 22286819?><pub-id pub-id-type="pmid">22286819</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>J.</given-names></name><name><surname>Zhong</surname><given-names>Y.-F.</given-names></name><name><surname>Wu</surname><given-names>Y.-P.</given-names></name><etal/></person-group><article-title>Carnosine attenuates cyclophosphamide-induced bone marrow suppression by reducing oxidative DNA damage</article-title><source><italic toggle="yes">Redox Biology</italic></source><year>2018</year><volume>14</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2017.08.003</pub-id><pub-id pub-id-type="other">2-s2.0-85027590190</pub-id><?supplied-pmid 28826042?><pub-id pub-id-type="pmid">28826042</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Nasser</surname><given-names>I. A.</given-names></name></person-group><article-title>In vivo prevention of cyclophosphamide-induced Ca<sup>2+</sup> dependent damage of rat heart and liver mitochondria by cyclosporin A</article-title><source><italic toggle="yes">Comparative Biochemistry and Physiology Part A: Molecular &#x00026; Integrative Physiology</italic></source><year>1998</year><volume>121</volume><issue>3</issue><fpage>209</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1016/S1095-6433(98)10135-6</pub-id><pub-id pub-id-type="other">2-s2.0-0032436596</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudharsan</surname><given-names>P. T.</given-names></name><name><surname>Mythili</surname><given-names>Y.</given-names></name><name><surname>Selvakumar</surname><given-names>E.</given-names></name><name><surname>Varalakshmi</surname><given-names>P.</given-names></name></person-group><article-title>Lupeol and its ester ameliorate the cyclophosphamide provoked cardiac lysosomal damage studied in rat</article-title><source><italic toggle="yes">Molecular and Cellular Biochemistry</italic></source><year>2006</year><volume>282</volume><issue>1-2</issue><fpage>23</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1007/s11010-006-1169-1</pub-id><pub-id pub-id-type="other">2-s2.0-29644435334</pub-id><?supplied-pmid 16317508?><pub-id pub-id-type="pmid">16317508</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gebhart</surname><given-names>E.</given-names></name></person-group><article-title>Anticlastogenicity in cultured mammalian cells</article-title><source><italic toggle="yes">Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis</italic></source><year>1992</year><volume>267</volume><issue>2</issue><fpage>211</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1016/0027-5107(92)90065-A</pub-id><pub-id pub-id-type="other">2-s2.0-0026577497</pub-id><?supplied-pmid 1376423?><pub-id pub-id-type="pmid">1376423</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patlolla</surname><given-names>A. K.</given-names></name><name><surname>Tchounwou</surname><given-names>P. B.</given-names></name></person-group><article-title>Cytogenetic evaluation of arsenic trioxide toxicity in Sprague&#x02013;Dawley rats</article-title><source><italic toggle="yes">Mutation Research/Genetic Toxicology and Environmental Mutagenesis</italic></source><year>2005</year><volume>587</volume><issue>1-2</issue><fpage>126</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1016/j.mrgentox.2005.08.007</pub-id><pub-id pub-id-type="other">2-s2.0-27144482690</pub-id><?supplied-pmid 16213187?><pub-id pub-id-type="pmid">16213187</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kour</surname><given-names>J.</given-names></name><name><surname>Ali</surname><given-names>M. N.</given-names></name><name><surname>Ganaie</surname><given-names>H. A.</given-names></name><name><surname>Tabassum</surname><given-names>N.</given-names></name></person-group><article-title>Amelioration of the cyclophosphamide induced genotoxic damage in mice by the ethanolic extract of <italic>Equisetum arvense</italic></article-title><source><italic toggle="yes">Toxicology Reports</italic></source><year>2017</year><volume>4</volume><fpage>226</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1016/j.toxrep.2017.05.001</pub-id><pub-id pub-id-type="other">2-s2.0-85019377651</pub-id><?supplied-pmid 28959643?><pub-id pub-id-type="pmid">28959643</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhawan</surname><given-names>A.</given-names></name><name><surname>Taurozzi</surname><given-names>J. S.</given-names></name><name><surname>Pandey</surname><given-names>A. K.</given-names></name><etal/></person-group><article-title>Stable colloidal dispersions of C60 fullerenes in water: evidence for genotoxicity</article-title><source><italic toggle="yes">Environmental Science &#x00026; Technology</italic></source><year>2006</year><volume>40</volume><issue>23</issue><fpage>7394</fpage><lpage>7401</lpage><pub-id pub-id-type="doi">10.1021/es0609708</pub-id><pub-id pub-id-type="other">2-s2.0-33845304728</pub-id><?supplied-pmid 17180994?><pub-id pub-id-type="pmid">17180994</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobsen</surname><given-names>N. R.</given-names></name><name><surname>Pojana</surname><given-names>G.</given-names></name><name><surname>White</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Genotoxicity, cytotoxicity, and reactive oxygen species induced by single&#x02010;walled carbon nanotubes and C<sub>60</sub> fullerenes in the FE1&#x02010;Muta&#x02122;Mouse lung epithelial cells</article-title><source><italic toggle="yes">Environmental and Molecular Mutagenesis</italic></source><year>2008</year><volume>49</volume><issue>6</issue><fpage>476</fpage><lpage>487</lpage><pub-id pub-id-type="doi">10.1002/em.20406</pub-id><pub-id pub-id-type="other">2-s2.0-48249096280</pub-id><?supplied-pmid 18618583?><pub-id pub-id-type="pmid">18618583</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Subiai</surname><given-names>S. N.</given-names></name><name><surname>Arlt</surname><given-names>V. M.</given-names></name><name><surname>Frickers</surname><given-names>P. E.</given-names></name><etal/></person-group><article-title>Merging nano-genotoxicology with eco-genotoxicology: an integrated approach to determine interactive genotoxic and sub-lethal toxic effects of C<sub>60</sub> fullerenes and fluoranthene in marine mussels, <italic>Mytilus</italic> sp</article-title><source><italic toggle="yes">Mutation Research/Genetic Toxicology and Environmental Mutagenesis</italic></source><year>2012</year><volume>745</volume><issue>1-2</issue><fpage>92</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.mrgentox.2011.12.019</pub-id><pub-id pub-id-type="other">2-s2.0-84860466564</pub-id><?supplied-pmid 22230430?><pub-id pub-id-type="pmid">22230430</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zakharenko</surname><given-names>L. P.</given-names></name><name><surname>Zakharov</surname><given-names>I. K.</given-names></name><name><surname>Vasiunina</surname><given-names>E. A.</given-names></name><name><surname>Karamysheva</surname><given-names>T. V.</given-names></name><name><surname>Danilenko</surname><given-names>A. M.</given-names></name><name><surname>Nikiforov</surname><given-names>A. A.</given-names></name></person-group><article-title>Determination of the genotoxicity of fullerene C60 and fullerol using the method of somatic mosaics on cells of <italic>Drosophila melanogaster</italic> wing and SOS-chromotest</article-title><source><italic toggle="yes">Genetika</italic></source><year>1997</year><volume>33</volume><issue>3</issue><fpage>405</fpage><lpage>409</lpage><?supplied-pmid 9244774?><pub-id pub-id-type="pmid">9244774</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinohara</surname><given-names>N.</given-names></name><name><surname>Matsumoto</surname><given-names>K.</given-names></name><name><surname>Endoh</surname><given-names>S.</given-names></name><name><surname>Maru</surname><given-names>J.</given-names></name><name><surname>Nakanishi</surname><given-names>J.</given-names></name></person-group><article-title>
<italic>In vitro</italic> and <italic>in vivo</italic> genotoxicity tests on fullerene C<sub>60</sub> nanoparticles</article-title><source><italic toggle="yes">Toxicology Letters</italic></source><year>2009</year><volume>191</volume><issue>2-3</issue><fpage>289</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1016/j.toxlet.2009.09.012</pub-id><pub-id pub-id-type="other">2-s2.0-70449519042</pub-id><?supplied-pmid 19772904?><pub-id pub-id-type="pmid">19772904</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>T.</given-names></name><name><surname>Takada</surname><given-names>H.</given-names></name><name><surname>Ito</surname><given-names>S.</given-names></name><name><surname>Matsubayashi</surname><given-names>K.</given-names></name><name><surname>Miwa</surname><given-names>N.</given-names></name><name><surname>Sawaguchi</surname><given-names>T.</given-names></name></person-group><article-title>Preclinical studies on safety of fullerene upon acute oral administration and evaluation for no mutagenesis</article-title><source><italic toggle="yes">Toxicology</italic></source><year>2006</year><volume>225</volume><issue>1</issue><fpage>48</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.tox.2006.05.001</pub-id><pub-id pub-id-type="other">2-s2.0-33745742443</pub-id><?supplied-pmid 16782258?><pub-id pub-id-type="pmid">16782258</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ema</surname><given-names>M.</given-names></name><name><surname>Imamura</surname><given-names>T.</given-names></name><name><surname>Suzuki</surname><given-names>H.</given-names></name><name><surname>Kobayashi</surname><given-names>N.</given-names></name><name><surname>Naya</surname><given-names>M.</given-names></name><name><surname>Nakanishi</surname><given-names>J.</given-names></name></person-group><article-title>Genotoxicity evaluation for single-walled carbon nanotubes in a battery of <italic>in vitro</italic> and <italic>in vivo</italic> assays</article-title><source><italic toggle="yes">Journal of Applied Toxicology</italic></source><year>2013</year><volume>33</volume><issue>9</issue><fpage>933</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1002/jat.2772</pub-id><pub-id pub-id-type="other">2-s2.0-84880702786</pub-id><?supplied-pmid 22763644?><pub-id pub-id-type="pmid">22763644</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afanasieva</surname><given-names>K. S.</given-names></name><name><surname>Prylutska</surname><given-names>S. V.</given-names></name><name><surname>Lozovik</surname><given-names>A. V.</given-names></name><etal/></person-group><article-title>C(60) fullerene prevents genotoxic effects of doxorubicin in human lymphocytes in vitro</article-title><source><italic toggle="yes">The Ukrainian Biochemical Journal</italic></source><year>2015</year><volume>87</volume><issue>1</issue><fpage>91</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.15407/ubj87.01.091</pub-id><pub-id pub-id-type="other">2-s2.0-84930813929</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prylutska</surname><given-names>S. V.</given-names></name><name><surname>Grynyuk</surname><given-names>I. I.</given-names></name><name><surname>Matyshevska</surname><given-names>O. P.</given-names></name><name><surname>Prylutskyy</surname><given-names>Y. I.</given-names></name><name><surname>Ritter</surname><given-names>U.</given-names></name><name><surname>Scharff</surname><given-names>P.</given-names></name></person-group><article-title>Anti&#x02010;oxidant properties of C<sub>60</sub> fullerenes <italic>in vitro</italic></article-title><source><italic toggle="yes">Fullerenes, Nanotubes and Carbon Nanostructures</italic></source><year>2008</year><volume>16</volume><issue>5-6</issue><fpage>698</fpage><lpage>705</lpage><pub-id pub-id-type="doi">10.1080/15363830802317148</pub-id><pub-id pub-id-type="other">2-s2.0-52949091200</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prylutska</surname><given-names>S. V.</given-names></name><name><surname>Grynyuk</surname><given-names>I. I.</given-names></name><name><surname>Grebinyk</surname><given-names>S. M.</given-names></name><etal/></person-group><article-title>Comparative study of biological action of fullerenes C<sub>60</sub> and carbon nanotubes in thymus cells</article-title><source><italic toggle="yes">Materialwissenschaft Und Werkstofftechnik</italic></source><year>2009</year><volume>40</volume><issue>4</issue><fpage>238</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1002/mawe.200900433</pub-id><pub-id pub-id-type="other">2-s2.0-67649191757</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saber</surname><given-names>T.</given-names></name><name><surname>Farag</surname><given-names>M.</given-names></name><name><surname>Cooper</surname><given-names>R.</given-names></name></person-group><article-title>Ameliorative effect of extra virgin olive oil on hexavalent chromium-induced nephrotoxicity and genotoxicity in rats</article-title><source><italic toggle="yes">Revue de M&#x000e9;decine V&#x000e9;t&#x000e9;rinaire</italic></source><year>2015</year><volume>166</volume><fpage>11</fpage><lpage>19</lpage></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabiani</surname><given-names>R.</given-names></name><name><surname>de Bartolomeo</surname><given-names>A.</given-names></name><name><surname>Rosignoli</surname><given-names>P.</given-names></name><name><surname>Servili</surname><given-names>M.</given-names></name><name><surname>Montedoro</surname><given-names>G. F.</given-names></name><name><surname>Morozzi</surname><given-names>G.</given-names></name></person-group><article-title>Cancer chemoprevention by hydroxytyrosol isolated from virgin olive oil through G1 cell cycle arrest and apoptosis</article-title><source><italic toggle="yes">European Journal of Cancer Prevention</italic></source><year>2002</year><volume>11</volume><issue>4</issue><fpage>351</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1097/00008469-200208000-00006</pub-id><pub-id pub-id-type="other">2-s2.0-0036684228</pub-id><?supplied-pmid 12195161?><pub-id pub-id-type="pmid">12195161</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machowetz</surname><given-names>A.</given-names></name><name><surname>Poulsen</surname><given-names>H. E.</given-names></name><name><surname>Gruendel</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Effect of olive oils on biomarkers of oxidative DNA stress in Northern and Southern Europeans</article-title><source><italic toggle="yes">The FASEB Journal</italic></source><year>2007</year><volume>21</volume><issue>1</issue><fpage>45</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1096/fj.06-6328com</pub-id><pub-id pub-id-type="other">2-s2.0-33845992189</pub-id><?supplied-pmid 17110467?><pub-id pub-id-type="pmid">17110467</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baati</surname><given-names>T.</given-names></name><name><surname>Bourasset</surname><given-names>F.</given-names></name><name><surname>Gharbi</surname><given-names>N.</given-names></name><etal/></person-group><article-title>The prolongation of the lifespan of rats by repeated oral administration of [60] fullerene</article-title><source><italic toggle="yes">Biomaterials</italic></source><year>2012</year><volume>33</volume><issue>19</issue><fpage>4936</fpage><lpage>4946</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2012.03.036</pub-id><pub-id pub-id-type="other">2-s2.0-84859842869</pub-id><?supplied-pmid 22498298?><pub-id pub-id-type="pmid">22498298</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elshater</surname><given-names>A. A.</given-names></name><name><surname>Haridy</surname><given-names>M. A. M.</given-names></name><name><surname>Salman</surname><given-names>M. M. A.</given-names></name><name><surname>Fayyad</surname><given-names>A. S.</given-names></name><name><surname>Hammad</surname><given-names>S.</given-names></name></person-group><article-title>Fullerene C<sub>60</sub> nanoparticles ameliorated cyclophosphamide-induced acute hepatotoxicity in rats</article-title><source><italic toggle="yes">Biomedicine &#x00026; Pharmacotherapy</italic></source><year>2018</year><volume>97</volume><fpage>53</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2017.10.134</pub-id><pub-id pub-id-type="other">2-s2.0-85032185105</pub-id><?supplied-pmid 29080458?><pub-id pub-id-type="pmid">29080458</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zietkiewicz</surname><given-names>E.</given-names></name><name><surname>Rafalski</surname><given-names>A.</given-names></name><name><surname>Labuda</surname><given-names>D.</given-names></name></person-group><article-title>Genome fingerprinting by simple sequence repeat (SSR)-anchored polymerase chain reaction amplification</article-title><source><italic toggle="yes">Genomics</italic></source><year>1994</year><volume>20</volume><issue>2</issue><fpage>176</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1006/geno.1994.1151</pub-id><pub-id pub-id-type="other">2-s2.0-0028316648</pub-id><?supplied-pmid 8020964?><pub-id pub-id-type="pmid">8020964</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharaf-Eldeen</surname><given-names>K.</given-names></name><name><surname>El-Ezabi</surname><given-names>M.</given-names></name><name><surname>Al-Bohaissi</surname><given-names>A.</given-names></name></person-group><article-title>The molecular changes of hepatocytes in tilapia zillh under the effect of the agricultural and industrial pollution in the river Nile, Egypt</article-title><source><italic toggle="yes">Egyptian Journal of Aquatic Biology and Fisheries</italic></source><year>2006</year><volume>10</volume><issue>2</issue><fpage>55</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.21608/ejabf.2006.1848</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yosida</surname><given-names>T. H.</given-names></name><name><surname>Amano</surname><given-names>K.</given-names></name></person-group><article-title>Autosomal polymorphism in laboratory bred and wild Norway rats, <italic>Rattus norvegicus</italic>, found in Misima</article-title><source><italic toggle="yes">Chromosoma</italic></source><year>1965</year><volume>16</volume><issue>6</issue><fpage>658</fpage><lpage>667</lpage><pub-id pub-id-type="doi">10.1007/BF00285115</pub-id><pub-id pub-id-type="other">2-s2.0-0013855097</pub-id><?supplied-pmid 5862838?><pub-id pub-id-type="pmid">5862838</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emadi</surname><given-names>A.</given-names></name><name><surname>Jones</surname><given-names>R. J.</given-names></name><name><surname>Brodsky</surname><given-names>R. A.</given-names></name></person-group><article-title>Cyclophosphamide and cancer: golden anniversary</article-title><source><italic toggle="yes">Nature Reviews Clinical Oncology</italic></source><year>2009</year><volume>6</volume><issue>11</issue><fpage>638</fpage><lpage>647</lpage><pub-id pub-id-type="doi">10.1038/nrclinonc.2009.146</pub-id><pub-id pub-id-type="other">2-s2.0-70350786392</pub-id><?supplied-pmid 19786984?><pub-id pub-id-type="pmid">19786984</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>A.</given-names></name><name><surname>Ueda</surname><given-names>T.</given-names></name><name><surname>Furuya</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Cyclophosphamide-induced bladder cancer in a patient with Wegener granuromatosis</article-title><source><italic toggle="yes">The Japanese Journal of Urology</italic></source><year>1999</year><volume>90</volume><issue>1</issue><fpage>53</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.5980/jpnjurol1989.90.53</pub-id><pub-id pub-id-type="other">2-s2.0-0033022758</pub-id><?supplied-pmid 10067308?><pub-id pub-id-type="pmid">10067308</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strzadala</surname><given-names>L.</given-names></name><name><surname>Rak</surname><given-names>J.</given-names></name><name><surname>Ziolo</surname><given-names>E.</given-names></name><name><surname>Kusnierczyk</surname><given-names>H.</given-names></name><name><surname>Radzikowski</surname><given-names>C.</given-names></name></person-group><article-title>Potentiation of cyclophosphamide-induced enhancement of experimental metastasis by splenectomy</article-title><source><italic toggle="yes">Archivum Immunologiae et Therapiae Experimentalis</italic></source><year>1989</year><volume>37</volume><fpage>399</fpage><lpage>403</lpage><pub-id pub-id-type="pmid">2639636</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popov</surname><given-names>B.</given-names></name><name><surname>Georgieva</surname><given-names>S.</given-names></name><name><surname>Gadjeva</surname><given-names>V.</given-names></name></person-group><article-title>Modulatory effects of total extract of <italic>Haberlea rhodopensis</italic> against the cyclophosphamide induced genotoxicity in rabbit lymphocytes in vivo</article-title><source><italic toggle="yes">Trakia Journal of Sciences</italic></source><year>2011</year><volume>9</volume><fpage>52</fpage><lpage>58</lpage></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murata</surname><given-names>M.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Midorikawa</surname><given-names>K.</given-names></name><name><surname>Oikawa</surname><given-names>S.</given-names></name><name><surname>Kawanishi</surname><given-names>S.</given-names></name></person-group><article-title>Oxidative DNA damage induced by a hydroperoxide derivative of cyclophosphamide</article-title><source><italic toggle="yes">Free Radical Biology &#x00026; Medicine</italic></source><year>2004</year><volume>37</volume><issue>6</issue><fpage>793</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2004.05.009</pub-id><pub-id pub-id-type="other">2-s2.0-4043064242</pub-id><?supplied-pmid 15304255?><pub-id pub-id-type="pmid">15304255</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sushma</surname><given-names>C.</given-names></name><name><surname>Rudrama Devi</surname><given-names>K.</given-names></name></person-group><article-title>Antigenotoxic effects of <italic>Aegle marmelos</italic> fruit extract in cyclophosphamide induced chromosomal aberrations and aberrant sperms in germ cells of Swiss albino mice</article-title><source><italic toggle="yes">International Journal of Pure &#x00026; Applied Bioscience</italic></source><year>2015</year><volume>3</volume><issue>5</issue><fpage>178</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.18782/2320-7051.2119</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shukla</surname><given-names>Y.</given-names></name><name><surname>Taneja</surname><given-names>P.</given-names></name></person-group><article-title>Antimutagenic effects of garlic extract on chromosomal aberrations</article-title><source><italic toggle="yes">Cancer Letters</italic></source><year>2002</year><volume>176</volume><issue>1</issue><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/S0304-3835(01)00774-1</pub-id><pub-id pub-id-type="other">2-s2.0-0037039709</pub-id><?supplied-pmid 11790451?><pub-id pub-id-type="pmid">11790451</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dutta</surname><given-names>D.</given-names></name><name><surname>Saravana Devi</surname><given-names>S.</given-names></name><name><surname>Krishnamurthi</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Modulatory effect of distillate of <italic>Ocimum sanctum</italic> leaf extract (Tulsi) on human lymphocytes against genotoxicants</article-title><source><italic toggle="yes">Biomedical and Environmental Sciences</italic></source><year>2007</year><volume>20</volume><fpage>p. 226</fpage><pub-id pub-id-type="pmid">17672214</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>V&#x000e1;vrov&#x000e1;</surname><given-names>J.</given-names></name><name><surname>&#x00158;ez&#x000e1;&#x0010d;ov&#x000e1;</surname><given-names>M.</given-names></name><name><surname>Pejchal</surname><given-names>J.</given-names></name></person-group><article-title>Fullerene nanoparticles and their anti-oxidative effects: a comparison to other radioprotective agents</article-title><source><italic toggle="yes">Journal of Applied Biomedicine</italic></source><year>2012</year><volume>10</volume><issue>1</issue><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.2478/v10136-012-0002-2</pub-id><pub-id pub-id-type="other">2-s2.0-84856594303</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mr&#x00111;anovi&#x00107;</surname><given-names>J.</given-names></name><name><surname>Jungi&#x00107;</surname><given-names>S.</given-names></name><name><surname>&#x00160;olaji&#x00107;</surname><given-names>S.</given-names></name><name><surname>Bogdanovi&#x00107;</surname><given-names>V.</given-names></name><name><surname>Juri&#x00161;i&#x00107;</surname><given-names>V.</given-names></name></person-group><article-title>Effects of orally administered antioxidants on micronuclei and sister chromatid exchange frequency in workers professionally exposed to antineoplastic agents</article-title><source><italic toggle="yes">Food and Chemical Toxicology</italic></source><year>2012</year><volume>50</volume><issue>8</issue><fpage>2937</fpage><lpage>2944</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2012.04.027</pub-id><pub-id pub-id-type="other">2-s2.0-84864043393</pub-id><?supplied-pmid 22546365?><pub-id pub-id-type="pmid">22546365</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theriot</surname><given-names>C. A.</given-names></name><name><surname>Casey</surname><given-names>R. C.</given-names></name><name><surname>Moore</surname><given-names>V. C.</given-names></name><etal/></person-group><article-title>Dendro[C60]fullerene DF-1 provides radioprotection to radiosensitive mammalian cells</article-title><source><italic toggle="yes">Radiation and Environmental Biophysics</italic></source><year>2010</year><volume>49</volume><issue>3</issue><fpage>437</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1007/s00411-010-0310-4</pub-id><pub-id pub-id-type="other">2-s2.0-77955465878</pub-id><?supplied-pmid 20582595?><pub-id pub-id-type="pmid">20582595</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Shen</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Cellular uptake and cytotoxic evaluation of fullerenol in different cell lines</article-title><source><italic toggle="yes">Toxicology</italic></source><year>2010</year><volume>269</volume><issue>2-3</issue><fpage>155</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1016/j.tox.2009.11.015</pub-id><pub-id pub-id-type="other">2-s2.0-77949917400</pub-id><?supplied-pmid 19941929?><pub-id pub-id-type="pmid">19941929</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aschberger</surname><given-names>K.</given-names></name><name><surname>Johnston</surname><given-names>H. J.</given-names></name><name><surname>Stone</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Review of fullerene toxicity and exposure&#x02014;appraisal of a human health risk assessment, based on open literature</article-title><source><italic toggle="yes">Regulatory Toxicology and Pharmacology</italic></source><year>2010</year><volume>58</volume><issue>3</issue><fpage>455</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.1016/j.yrtph.2010.08.017</pub-id><pub-id pub-id-type="other">2-s2.0-77957115833</pub-id><?supplied-pmid 20800639?><pub-id pub-id-type="pmid">20800639</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>H. J.</given-names></name><name><surname>Hutchison</surname><given-names>G. R.</given-names></name><name><surname>Christensen</surname><given-names>F. M.</given-names></name><name><surname>Aschberger</surname><given-names>K.</given-names></name><name><surname>Stone</surname><given-names>V.</given-names></name></person-group><article-title>The biological mechanisms and physicochemical characteristics responsible for driving fullerene toxicity</article-title><source><italic toggle="yes">Toxicological Sciences</italic></source><year>2010</year><volume>114</volume><issue>2</issue><fpage>162</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1093/toxsci/kfp265</pub-id><pub-id pub-id-type="other">2-s2.0-77951541621</pub-id><?supplied-pmid 19901017?><pub-id pub-id-type="pmid">19901017</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aly</surname><given-names>F. M.</given-names></name><name><surname>Kotb</surname><given-names>A. M.</given-names></name><name><surname>Haridy</surname><given-names>M. A. M.</given-names></name><name><surname>Hammad</surname><given-names>S.</given-names></name></person-group><article-title>Impacts of fullerene C60 and virgin olive oil on cadmium-induced genotoxicity in rats</article-title><source><italic toggle="yes">Science of The Total Environment</italic></source><year>2018</year><volume>630</volume><fpage>750</fpage><lpage>756</lpage><pub-id pub-id-type="doi">10.1016/j.scitotenv.2018.02.205</pub-id><pub-id pub-id-type="other">2-s2.0-85042712297</pub-id><?supplied-pmid 29499533?><pub-id pub-id-type="pmid">29499533</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammed</surname><given-names>E. T.</given-names></name><name><surname>Hashem</surname><given-names>K. S.</given-names></name><name><surname>Rheim</surname><given-names>M. R. A.</given-names></name></person-group><article-title>Biochemical study on the impact of <italic>Nigella sativa</italic> and virgin olive oils on cadmium-induced nephrotoxicity and neurotoxicity in rats</article-title><source><italic toggle="yes">Journal of Investigational Biochemistry</italic></source><year>2014</year><volume>3</volume><issue>2</issue><fpage>71</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.5455/jib.20140716041908</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nousis</surname><given-names>L.</given-names></name><name><surname>Doulias</surname><given-names>P.-T.</given-names></name><name><surname>Aligiannis</surname><given-names>N.</given-names></name><etal/></person-group><article-title>DNA protecting and genotoxic effects of olive oil related components in cells exposed to hydrogen peroxide</article-title><source><italic toggle="yes">Free Radical Research</italic></source><year>2005</year><volume>39</volume><issue>7</issue><fpage>787</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1080/10715760500045806</pub-id><pub-id pub-id-type="other">2-s2.0-21844470451</pub-id><pub-id pub-id-type="pmid">16036359</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>PCR products of liver genomic DNA after treatments with cyclophosphamide, fullerene nanoparticles (C<sub>60</sub>), and virgin olive oil; lane M: DNA marker; lane 1: control; lane 2: CP group; lane 3: C<sub>60</sub> group; lane 4: CP&#x02009;+&#x02009;C<sub>60</sub> group; and lane 5: CP&#x02009;+&#x02009;VOO group.</p></caption><graphic xlink:href="OMCL2018-1261356.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>PCR products of heart genomic DNA after treatments with CP, fullerene nanoparticles (C<sub>60</sub>), and virgin olive oil; lane M: DNA marker; lane 1: control; lane 2: CP group; lane 3: C<sub>60</sub> group; lane 4: CP&#x02009;+&#x02009;C<sub>60</sub> group; and lane 5: CP&#x02009;+&#x02009;VOO group.</p></caption><graphic xlink:href="OMCL2018-1261356.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Metaphase-chromosomal aberrations in bone marrow cells showing the effect of CP treatment in group 2; (a and b) normal metaphase. Deletion in chromatid (<italic>D</italic>), ring chromosomes (<italic>R</italic>), dicentric chromosome (<italic>D</italic><sub>c</sub>), and fragment chromosomes (<italic>F</italic>), and polyploidy in chromosome numbers was observed in (h).</p></caption><graphic xlink:href="OMCL2018-1261356.003"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>The primer code and nucleotide sequences.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Primer</th><th align="center" rowspan="1" colspan="1">Primer sequence 5&#x02032;-3&#x02032;</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">ISSR-1</td><td align="center" rowspan="1" colspan="1">5&#x02032;-ACACACACACACACACYA-3&#x02032;</td></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-2</td><td align="center" rowspan="1" colspan="1">5&#x02032;-AGAGAGAGAGAGAGAGYT-3&#x02032;</td></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-3</td><td align="center" rowspan="1" colspan="1">5&#x02032;-CTCCTCCTCCTCCTCTT-3&#x02032;</td></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-4</td><td align="center" rowspan="1" colspan="1">5&#x02032;-CTCTCTCTCTCTCTCTCG-3&#x02032;</td></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-5</td><td align="center" rowspan="1" colspan="1">5&#x02032;-TCTCTCTCTCTCTCTCA-3&#x02032;</td></tr></tbody></table><table-wrap-foot><fn><p>Nucleotide code: A&#x02009;=&#x02009;adenine, C&#x02009;=&#x02009;cytosine, G&#x02009;=&#x02009;guanine, T&#x02009;=&#x02009;thymine, and Y&#x02009;=&#x02009;Cor T.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Number and frequency of the obtained bands using ISSR in liver and heart tissues after treatment with CP, C<sub>60</sub>, and VOO.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Primers</th><th align="center" rowspan="2" colspan="1">Total band numbers</th><th align="center" rowspan="2" colspan="1">Mobility range (bp)</th><th align="center" colspan="5" rowspan="1">Number of bands</th><th align="center" rowspan="2" colspan="1">Band frequency (mean&#x02009;&#x000b1;&#x02009;SE)</th></tr><tr><th align="center" rowspan="1" colspan="1">Control</th><th align="center" rowspan="1" colspan="1">CP</th><th align="center" rowspan="1" colspan="1">C<sub>60</sub></th><th align="center" rowspan="1" colspan="1">CP&#x02009;+&#x02009;C<sub>60</sub></th><th align="center" rowspan="1" colspan="1">CP&#x02009;+&#x02009;VOO</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<italic>Rat liver</italic>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-1</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">170&#x02013;670</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">0.98&#x02009;&#x000b1;&#x02009;0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-2</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">160&#x02013;850</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">0.81&#x02009;&#x000b1;&#x02009;0.07</td></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-3</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">190&#x02013;1000</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">0.85&#x02009;&#x000b1;&#x02009;0.06</td></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-4</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">260&#x02013;1400</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">0.97&#x02009;&#x000b1;&#x02009;0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-5</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">290&#x02013;1000</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">1.00&#x02009;&#x000b1;&#x02009;0.00</td></tr><tr><td align="left" rowspan="1" colspan="1">Sum</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">
<bold>57</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>52</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>57</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>56</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>61</bold>
</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Rat heart</italic>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-1</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">160&#x02013;670</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">0.82&#x02009;&#x000b1;&#x02009;0.08</td></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-2</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">160&#x02013;850</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">0.95&#x02009;&#x000b1;&#x02009;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-3</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">190&#x02013;850</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">0.83&#x02009;&#x000b1;&#x02009;0.06</td></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-4</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">260&#x02013;1400</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">0.87&#x02009;&#x000b1;&#x02009;0.06</td></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-5</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">290&#x02013;1000</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">
<bold>7</bold>
</td><td align="center" rowspan="1" colspan="1">0.83&#x02009;&#x000b1;&#x02009;0.10</td></tr><tr><td align="left" rowspan="1" colspan="1">Sum</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">
<bold>53</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>46</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>53</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>50</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>55</bold>
</td><td rowspan="1" colspan="1"/></tr></tbody></table></table-wrap><table-wrap id="tab3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Detected polymorphism for the ISSR primer in hepatic and cardiac tissues of rats after treatment with CP, C<sub>60</sub>, and VOO.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Primer</th><th align="center" colspan="3" rowspan="1">CP</th><th align="center" colspan="3" rowspan="1">C<sub>60</sub></th><th align="center" colspan="3" rowspan="1">CP&#x02009;+&#x02009;C<sub>60</sub></th><th align="center" colspan="3" rowspan="1">CP&#x02009;+&#x02009;VOO</th></tr><tr><th align="center" rowspan="1" colspan="1">Bands (number)</th><th align="center" rowspan="1" colspan="1">Polyploidy (number)</th><th align="center" rowspan="1" colspan="1">Polymorphism (%)</th><th align="center" rowspan="1" colspan="1">Bands (number)</th><th align="center" rowspan="1" colspan="1">Polyploidy (number)</th><th align="center" rowspan="1" colspan="1">Polymorphism (%)</th><th align="center" rowspan="1" colspan="1">Bands (number)</th><th align="center" rowspan="1" colspan="1">Polyploidy (number)</th><th align="center" rowspan="1" colspan="1">Polymorphism (%)</th><th align="center" rowspan="1" colspan="1">Bands (number)</th><th align="center" rowspan="1" colspan="1">Polyploidy (number)</th><th align="center" rowspan="1" colspan="1">Polymorphism (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<italic>Liver</italic>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-1</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">9.1</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">9.1</td></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-2</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">36.4</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">28.6</td></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-3</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">71.4</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">8.3</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-4</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">6.7</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">7.1</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">6.7</td></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-5</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Sum</td><td align="center" rowspan="1" colspan="1">52</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">21.2</td><td align="center" rowspan="1" colspan="1">57</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">56</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">8.9</td><td align="center" rowspan="1" colspan="1">61</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">9.8</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Heart</italic>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-1</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-2</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">9.1</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">9.1</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">9.1</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">8.3</td></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-3</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">33.3</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">16.7</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">42.9</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">20</td></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-4</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">36.4</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">15.4</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">7.1</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">20</td></tr><tr><td align="left" rowspan="1" colspan="1">ISSR-5</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">14.3</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">14.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Sum</td><td align="center" rowspan="1" colspan="1">46</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">32.6</td><td align="center" rowspan="1" colspan="1">53</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">11.3</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">55</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">12.7</td></tr></tbody></table></table-wrap><table-wrap id="tab4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Chromosomal aberrations in rat bone marrow cells after treatment with CP, C<sub>60</sub>, and VOO.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Groups</th><th align="center" rowspan="2" colspan="1">Aberration cells (number)</th><th align="center" colspan="5" rowspan="1">Chromosomal aberration</th><th align="center" colspan="2" rowspan="1">Total aberrations</th><th align="center" rowspan="2" colspan="1">Average number of aberration (mean&#x02009;&#x000b1;&#x02009;SEM)</th></tr><tr><th align="center" rowspan="1" colspan="1">
<italic>R</italic> (number)</th><th align="center" rowspan="1" colspan="1">
<italic>D</italic> (number)</th><th align="center" rowspan="1" colspan="1">
<italic>D</italic>
<sub>c</sub> (number)</th><th align="center" rowspan="1" colspan="1">
<italic>F</italic> (number)</th><th align="center" rowspan="1" colspan="1">Poly (number)</th><th align="center" rowspan="1" colspan="1">Number</th><th align="center" rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Control</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">0.40&#x02009;&#x000b1;&#x02009;0.24</td></tr><tr><td align="left" rowspan="1" colspan="1">CP</td><td align="center" rowspan="1" colspan="1">95</td><td align="center" rowspan="1" colspan="1">80</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">115</td><td align="center" rowspan="1" colspan="1">57.5</td><td align="center" rowspan="1" colspan="1">23.00&#x02009;&#x000b1;&#x02009;14.28<sup>&#x02217;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">C<sub>60</sub></td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">41</td><td align="center" rowspan="1" colspan="1">20.5</td><td align="center" rowspan="1" colspan="1">8.20&#x02009;&#x000b1;&#x02009;3.29<sup>&#x02217;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">CP&#x02009;+&#x02009;C<sub>60</sub></td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">52</td><td align="center" rowspan="1" colspan="1">26.0</td><td align="center" rowspan="1" colspan="1">10.40&#x02009;&#x000b1;&#x02009;5.10<sup>&#x02217;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">CP&#x02009;+&#x02009;VOO</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">56</td><td align="center" rowspan="1" colspan="1">28.0</td><td align="center" rowspan="1" colspan="1">11.20&#x02009;&#x000b1;&#x02009;6.23<sup>&#x02217;</sup></td></tr></tbody></table><table-wrap-foot><fn><p>
<italic>R</italic>&#x02009;=&#x02009;ring chromosome, <italic>D</italic>&#x02009;=&#x02009;deletion in chromatid, <italic>D</italic><sub>c</sub>&#x02009;=&#x02009;dicentric chromosome, <italic>F</italic>&#x02009;=&#x02009;fragmentation chromosomes, and Poly&#x02009;=&#x02009;polyploidy chromosomes. Values are mean of replicates&#x02009;&#x000b1;&#x02009;SEM. <sup>&#x02217;</sup>Significant at <italic>P</italic> &#x0003c; 0.05.</p></fn></table-wrap-foot></table-wrap></floats-group></article>